Advanced search
1 file | 673.12 KB

Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA

Pieter De Visschere (UGent) , Nicolaas Lumen (UGent) , Piet Ost (UGent) , Karel Decaestecker (UGent) , EVA PATTYN (UGent) and Geert Villeirs (UGent)
(2017) CLINICAL RADIOLOGY. 72(1). p.23-32
Author
Organization
Keywords
MULTIPARAMETRIC MRI, REFERENCE-STANDARD, GUIDED BIOPSIES, SCORING SYSTEM, LOCALIZATION, METAANALYSIS, COHORT, PERFORMANCE, VALIDATION, GUIDELINES

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 673.12 KB

Citation

Please use this url to cite or link to this publication:

Chicago
De Visschere, Pieter, Nicolaas Lumen, Piet Ost, Karel Decaestecker, EVA PATTYN, and Geert Villeirs. 2017. “Dynamic Contrast-enhanced Imaging Has Limited Added Value over T2-weighted Imaging and Diffusion-weighted Imaging When Using PI-RADSv2 for Diagnosis of Clinically Significant Prostate Cancer in Patients with Elevated PSA.” Clinical Radiology 72 (1): 23–32.
APA
De Visschere, Pieter, Lumen, N., Ost, P., Decaestecker, K., PATTYN, E., & Villeirs, G. (2017). Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. CLINICAL RADIOLOGY, 72(1), 23–32.
Vancouver
1.
De Visschere P, Lumen N, Ost P, Decaestecker K, PATTYN E, Villeirs G. Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. CLINICAL RADIOLOGY. 2017;72(1):23–32.
MLA
De Visschere, Pieter, Nicolaas Lumen, Piet Ost, et al. “Dynamic Contrast-enhanced Imaging Has Limited Added Value over T2-weighted Imaging and Diffusion-weighted Imaging When Using PI-RADSv2 for Diagnosis of Clinically Significant Prostate Cancer in Patients with Elevated PSA.” CLINICAL RADIOLOGY 72.1 (2017): 23–32. Print.
@article{8168113,
  author       = {De Visschere, Pieter and Lumen, Nicolaas and Ost, Piet and Decaestecker, Karel and PATTYN, EVA and Villeirs, Geert},
  issn         = {0009-9260},
  journal      = {CLINICAL RADIOLOGY},
  keyword      = {MULTIPARAMETRIC MRI,REFERENCE-STANDARD,GUIDED BIOPSIES,SCORING SYSTEM,LOCALIZATION,METAANALYSIS,COHORT,PERFORMANCE,VALIDATION,GUIDELINES},
  language     = {eng},
  number       = {1},
  pages        = {23--32},
  title        = {Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA},
  url          = {http://dx.doi.org/10.1016/j.crad.2016.09.011},
  volume       = {72},
  year         = {2017},
}

Altmetric
View in Altmetric
Web of Science
Times cited: